Roche says its new interim update on hemophilia A drug is positive. But it’s hard to gauge.
Roche today sent out a small, blurry snapshot of the interim data from a Phase III study of emicizumab in children suffering from hemophilia A …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
